Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hi-Tech CEO Wheat Arrested In FDA Investigation Of Steroid-Spiked Supplements

Executive Summary

Hi-Tech Pharmaceuticals CEO Jared Wheat and an associate face 18 criminal charges in federal court alleging they falsified FDA documents and distributed as supplements products containing steroid ingredient. Wheat is appealing the indictment to federal circuit court.

Advertisement

Related Content

Hi-Tech DMAA Ruling, Recalls: Health And Wellness Industry News
USPlabs' DMAA Supplement Source Convicted In Separate Criminal Case
GNC Supply Chain Reform Pays Dividends In DoJ Settlement From DMAA Investigation
Industry Roundup: GMP Warnings, Spiked Product Recall, UK Ads
Hi-Tech Avoids FTC Contempt Charge, But Not The Judge
Hi-Tech Hunts Growth As FTC Picks Up Scent On Disputed Weight Loss Claims
In Brief: Shasun Buys Nuprin, DSM And GSK Earnings, Ad Claims Referred To FTC
Hi-Tech Lawsuit Calls FDA DMAA Enforcement “Bullying Tactics”
USPlabs Crafts DMAA Defense As Shield Against Further Damage
Hi-Tech CEO sentenced for fake drugs

Topics

Related Companies

Related Deals

What to read next

Advertisement
UsernamePublicRestriction

Register

RS121239

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel